Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Granada

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Disease Models & Mechanisms|May 14, 2021
Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studiesLourdes Farre, Gabriela Sanz, Neus Ruiz-Xivillé, et al.
American Journal of Hematology|April 30, 2025
Integration of Optical Genome Mapping in the Cytogenomic and Molecular Work-Up of Hematological Malignancies: Expert Recommendations From the International Consortium for Optical Genome MappingRashmi Kanagal-Shamanna, Anna Puiggros, Isabel Granada, et al.
British Journal of Haematology|September 22, 2021
Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocolsJordi Ribera, Isabel Granada, Mireia Morgades, et al.
Genes, Chromosomes & Cancer|August 1, 2017
Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanismsJordi Ribera, Lurdes Zamora, Mireia Morgades, et al.
Cancer|August 14, 2014
Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocolsCristina Motlló, Josep-María Ribera, Mireia Morgades, et al.
Blood|February 15, 2022
Guiding the global evolution of cytogenetic testing for hematologic malignanciesYassmine M N Akkari, Linda B Baughn, Adrian M Dubuc, et al.
Cytometry. Part B, Clinical Cytometry|June 13, 2020
FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot studyMarc Sorigue, Jordi Junca, Christelle Ferra, et al.
Genes, Chromosomes & Cancer|September 25, 2018
Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significanceJulie Schanz, Francesc Solé, Mar Mallo, et al.
European Journal of Haematology|April 4, 2020
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocolsMarta Sitges, Blanca Boluda, Ana Garrido, et al.
British Journal of Haematology|July 23, 2021
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutationsIván Martín, Eva Villamón, Rosario Abellán, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Disease Models & Mechanisms|May 14, 2021
Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studiesLourdes Farre, Gabriela Sanz, Neus Ruiz-Xivillé, et al.
American Journal of Hematology|April 30, 2025
Integration of Optical Genome Mapping in the Cytogenomic and Molecular Work-Up of Hematological Malignancies: Expert Recommendations From the International Consortium for Optical Genome MappingRashmi Kanagal-Shamanna, Anna Puiggros, Isabel Granada, et al.
British Journal of Haematology|September 22, 2021
Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocolsJordi Ribera, Isabel Granada, Mireia Morgades, et al.
Genes, Chromosomes & Cancer|August 1, 2017
Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanismsJordi Ribera, Lurdes Zamora, Mireia Morgades, et al.
Cancer|August 14, 2014
Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocolsCristina Motlló, Josep-María Ribera, Mireia Morgades, et al.
Blood|February 15, 2022
Guiding the global evolution of cytogenetic testing for hematologic malignanciesYassmine M N Akkari, Linda B Baughn, Adrian M Dubuc, et al.
Cytometry. Part B, Clinical Cytometry|June 13, 2020
FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot studyMarc Sorigue, Jordi Junca, Christelle Ferra, et al.
Genes, Chromosomes & Cancer|September 25, 2018
Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significanceJulie Schanz, Francesc Solé, Mar Mallo, et al.
European Journal of Haematology|April 4, 2020
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocolsMarta Sitges, Blanca Boluda, Ana Garrido, et al.
British Journal of Haematology|July 23, 2021
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutationsIván Martín, Eva Villamón, Rosario Abellán, et al.
Pageof 6